Knock-out-Zertifikate finden

Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.

 

► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.

Ihre Auswahl:
12 Ergebnisse
MJ8CVKEASY EUWAX
Crinetics Pharmaceuticals Inc./Faktor/Long [4]/MS
-
-
call
Crinetics Pharmaceuticals Inc.
62,917
62,917
3,952
25,010 %
-
Morgan Stanley
MK4BMQEASY EUWAX
Crinetics Pharmaceuticals Inc./Faktor/Long [3]/MS
-
-
call
Crinetics Pharmaceuticals Inc.
55,926
55,926
2,953
33,342 %
-
Morgan Stanley
MK4BMREASY EUWAX
Crinetics Pharmaceuticals Inc./Faktor/Long [4]/MS
-
-
call
Crinetics Pharmaceuticals Inc.
62,917
62,917
3,945
25,010 %
-
Morgan Stanley
MM1ZXLEASY EUWAX
Crinetics Pharmaceuticals Inc./Faktor/Long [2]/MS
-
-
call
Crinetics Pharmaceuticals Inc.
41,944
41,944
1,984
50,007 %
-
Morgan Stanley
MM1ZXMEASY EUWAX
Crinetics Pharmaceuticals Inc./Faktor/Long [5]/MS
-
-
call
Crinetics Pharmaceuticals Inc.
67,111
67,111
-
20,011 %
-
Morgan Stanley
MM5BKEEASY EUWAX
Crinetics Pharmaceuticals Inc./Faktor/Short [3]/MS
-
-
put
Crinetics Pharmaceuticals Inc.
111,824
111,824
2,889
33,282 %
-
Morgan Stanley
MM5R1JEASY EUWAX
Crinetics Pharmaceuticals Inc./Faktor/Long [5]/MS
-
-
call
Crinetics Pharmaceuticals Inc.
67,111
67,111
-
20,011 %
-
Morgan Stanley
MN11ZPEASY EUWAX
Crinetics Pharmaceuticals Inc./Faktor/Short [5]/MS
-
-
put
Crinetics Pharmaceuticals Inc.
100,642
100,642
-
19,954 %
-
Morgan Stanley
MN21MLEASY EUWAX
Crinetics Pharmaceuticals Inc./Faktor/Short [4]/MS
-
-
put
Crinetics Pharmaceuticals Inc.
104,835
104,835
3,904
24,952 %
-
Morgan Stanley
MR11HEEASY EUWAX
Crinetics Pharmaceuticals Inc./Faktor/Long [5]/MS
-
-
call
Crinetics Pharmaceuticals Inc.
67,111
67,111
-
20,011 %
-
Morgan Stanley
MR151BEASY EUWAX
Crinetics Pharmaceuticals Inc./Faktor/Long [4]/MS
-
-
call
Crinetics Pharmaceuticals Inc.
62,917
62,917
-
25,010 %
-
Morgan Stanley
MR1Y4ZEASY EUWAX
Crinetics Pharmaceuticals Inc./Faktor/Short [2]/MS
-
-
put
Crinetics Pharmaceuticals Inc.
125,802
125,802
-
49,943 %
-
Morgan Stanley